Purpose: The pharmacology, activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, dosage, and place in therapy of telavancin are reviewed. Summary ...

Telavancin is under review by FDA (NDA filed December 2006) for use in treating complicated skin and soft-tissue infections caused by gram-positive bacteria. The manufacturer is actively ...